Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study

NCT03190473 is registered in ClinicalTrials.gov with Svelte Medical Systems, Inc. as lead sponsor.

NCT NCT03190473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03190473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The OPTIMIZE Trial to Assess the Procedural and Clinical Value of the Svelte IDS and RX Sirolimus Eluting Coronary Stent Systems for the Treatment of Atherosclerotic Lesions in a Randomized Study
Lead sponsor
Svelte Medical Systems, Inc.
Phase
Not applicable
Overall status
Terminated
Start date
January 2, 2018
Completion date
March 8, 2023
Enrollment
1,630 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

acute coronary syndrome